Isabelle Bonnet

994 total citations
33 papers, 554 citations indexed

About

Isabelle Bonnet is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Isabelle Bonnet has authored 33 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Oncology. Recurrent topics in Isabelle Bonnet's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Isabelle Bonnet is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Isabelle Bonnet collaborates with scholars based in France, Luxembourg and United States. Isabelle Bonnet's co-authors include Éric Perrier, S. Briançon, Kawthar Bouchemal, N. Zydowicz, Hatem Fessi, Marie‐Hélène Baron, J. Robert, Yves Chevalier, Alexandra Aubry and Matthieu Schmidt and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Isabelle Bonnet

32 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Bonnet France 13 104 97 72 70 70 33 554
Didem Kart Türkiye 15 149 1.4× 33 0.3× 61 0.8× 141 2.0× 68 1.0× 41 508
Jesil Mathew Aranjani India 16 93 0.9× 79 0.8× 47 0.7× 239 3.4× 95 1.4× 60 808
Yun He China 15 43 0.4× 75 0.8× 158 2.2× 89 1.3× 63 0.9× 46 724
Gabriela Corrêa Carvalho Brazil 14 54 0.5× 48 0.5× 153 2.1× 106 1.5× 67 1.0× 37 623
Prashant Shukla India 20 66 0.6× 115 1.2× 186 2.6× 223 3.2× 109 1.6× 52 916
Ambak Kumar India 13 43 0.4× 150 1.5× 92 1.3× 71 1.0× 24 0.3× 54 599
Joe M. Viljoen South Africa 12 43 0.4× 76 0.8× 42 0.6× 69 1.0× 78 1.1× 27 477
Maria Vittoria Mauro Italy 11 77 0.7× 117 1.2× 35 0.5× 76 1.1× 62 0.9× 33 396
Andra-Cristina Bostănaru Romania 13 68 0.7× 33 0.3× 109 1.5× 49 0.7× 29 0.4× 30 480
Shyam Lal Mudavath India 16 57 0.5× 75 0.8× 99 1.4× 179 2.6× 21 0.3× 43 659

Countries citing papers authored by Isabelle Bonnet

Since Specialization
Citations

This map shows the geographic impact of Isabelle Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Bonnet more than expected).

Fields of papers citing papers by Isabelle Bonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Bonnet. The network helps show where Isabelle Bonnet may publish in the future.

Co-authorship network of co-authors of Isabelle Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Bonnet. A scholar is included among the top collaborators of Isabelle Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Bonnet. Isabelle Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnet, Isabelle, Mickael Orgeur, Florence Brossier, et al.. (2025). Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148. Microbiology Spectrum. 13(7). e0322424–e0322424. 1 indexed citations
2.
Gerussi, Valentina, Thomas Nordahl Petersen, Isabelle Bonnet, et al.. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerging infectious diseases. 31(3). 633–636.
3.
4.
Aubry, Alexandra, Wladimir Sougakoff, Matthieu Revest, et al.. (2022). atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure. Emerging infectious diseases. 28(5). 1062–1064. 5 indexed citations
5.
Coquan, Elodie, Pierre-Emmanuel Brachet, Idlir Licaj, et al.. (2021). CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure. BMC Cancer. 21(1). 1054–1054. 3 indexed citations
6.
7.
Haddad, Élie, et al.. (2021). Infective endocarditis due to Neisseria elongata: A case report and literature review. Infectious Diseases Now. 51(7). 622–626. 5 indexed citations
8.
Aubry, Alexandra, et al.. (2021). Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB® Assay. Antibiotics. 10(7). 797–797. 1 indexed citations
9.
Sougakoff, Wladimir, Franck Bielle, Isabelle Bonnet, et al.. (2020). Unusual subdural empyema in a homeless patient diagnosed by molecular approach: a case report. BMC Infectious Diseases. 20(1). 357–357. 3 indexed citations
10.
Luyt, Charles‐Édouard, Guillaume Hékimian, Isabelle Bonnet, et al.. (2020). Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational study. Critical Care. 24(1). 378–378. 33 indexed citations
11.
Bonnet, Isabelle, É. Fourniols, Stéphane Mitrovic, et al.. (2019). Erwinia billingiaeas Unusual Cause of Septic Arthritis, France, 2017. Emerging infectious diseases. 25(8). 1587–1589. 8 indexed citations
12.
Luyt, Charles‐Édouard, Morgane Faure, Isabelle Bonnet, et al.. (2019). Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients. International Journal of Antimicrobial Agents. 53(5). 547–552. 9 indexed citations
13.
Bonnet, Isabelle, H. Meugnier, François Vandenesch, et al.. (2018). High prevalence of spa type t571 among methicillin-susceptible Staphylococcus aureus from bacteremic patients in a French University Hospital. PLoS ONE. 13(10). e0204977–e0204977. 19 indexed citations
14.
Bonnet, Isabelle, et al.. (2018). Bénéfices médicoéconomiques des formes sous-cutanées de trastuzumab et de rituximab en hospitalisation de jour (étude SCuBA). Bulletin du Cancer. 105(10). 862–872. 5 indexed citations
15.
16.
Chibaudel, Benoist, Olivier Bouché, Éveline Boucher, et al.. (2015). Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer. Clinical Colorectal Cancer. 15(3). 250–256. 9 indexed citations
17.
Vogelgesang, B., et al.. (2010). In vitro and in vivo efficacy of sulfo‐carrabiose, a sugar‐based cosmetic ingredient with anti‐cellulite properties. International Journal of Cosmetic Science. 33(2). 120–125. 24 indexed citations
18.
Chevalier, Yves, et al.. (2008). Block copolymers of the type poly(caprolactone)-b-poly(ethylene oxide) for the preparation and stabilization of nanoemulsions. International Journal of Pharmaceutics. 362(1-2). 153–162. 43 indexed citations
19.
Perrier, Éric, et al.. (2006). Release of antimicrobial actives from microcapsules by the action of axillary bacteria. International Journal of Cosmetic Science. 28(2). 103–108. 25 indexed citations
20.
Bouchemal, Kawthar, S. Briançon, Éric Perrier, et al.. (2003). Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. International Journal of Pharmaceutics. 269(1). 89–100. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Didem Kart Breakdown of academic impact, for papers by Jesil Mathew Aranjani Breakdown of academic impact, for papers by Yun He Breakdown of academic impact, for papers by Gabriela Corrêa Carvalho Breakdown of academic impact, for papers by Prashant Shukla Breakdown of academic impact, for papers by Ambak Kumar Breakdown of academic impact, for papers by Joe M. Viljoen Breakdown of academic impact, for papers by Maria Vittoria Mauro Breakdown of academic impact, for papers by Andra-Cristina Bostănaru Breakdown of academic impact, for papers by Shyam Lal Mudavath
Rankless by CCL
2026